retatrutide compounded Glass Vial Injections Stock Photo 2744059121 Have you heard? The Retatrutide

eligible Medicare patients can access FDA-approved GLP-1 medications for $50/month through the CMS Medicare GLP-1 Bridge Program - a different pathway worth evaluating before enrolling in a cash-pay compounded program FDA adverse event data (as of May 21, 2026): FDA had received more than 1,700 adverse events associated with compounded semaglutide and tirzepatide combined - a safety signal not specific to Omzo but material context for any compounded GLP-1 enrollment decision

This differs from a perceived plateau where weight loss stalls but appetite control remains intact

GLP-1 ,

GLP-1 suppresses glucagon release, which helps lower fasting and postprandial blood glucose levels

The doctors begin with a detailed health assessment, including your medical history, current weight, lifestyle, and any underlying conditions

The chart below illustrates our anticipated market split